Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth C Wright

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Hepatology (Baltimore, Md.)|June 30, 2005
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohortAnna S F Lok, Marc G Ghany, Zachary D Goodman, et al.
Hepatology (Baltimore, Md.)|September 26, 2008
Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis CChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Journal of Hepatology|September 2, 2005
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C TrialAdrian M Di Bisceglie, Richard K Sterling, Raymond T Chung, et al.
Hepatology Communications|May 9, 2022
Abnormal liver tests are not sufficient for diagnosis of hepatic graft-versus-host disease in critically ill patientsAlexander H Yang, Mai Ai Thanda Han, Niharika Samala, et al.
Hepatology (Baltimore, Md.)|January 27, 2010
Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trialJames E Everhart, Elizabeth C Wright, Zachary D Goodman, et al.
Transplantation and Cellular Therapy|July 25, 2022
Characterization of Hepatic Dysfunction in Subjects Diagnosed With Chronic GVHD by NIH Consensus CriteriaAlexander H Yang, Ma Ai Thanda Han, Niharika Samala, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis CJules L Dienstag, Marc G Ghany, Timothy R Morgan, et al.
Hepatology (Baltimore, Md.)|May 13, 2009
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trialTania Mara Welzel, Timothy R Morgan, Herbert L Bonkovsky, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Hepatology (Baltimore, Md.)|June 30, 2005
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohortAnna S F Lok, Marc G Ghany, Zachary D Goodman, et al.
Hepatology (Baltimore, Md.)|September 26, 2008
Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis CChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Journal of Hepatology|September 2, 2005
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C TrialAdrian M Di Bisceglie, Richard K Sterling, Raymond T Chung, et al.
Hepatology Communications|May 9, 2022
Abnormal liver tests are not sufficient for diagnosis of hepatic graft-versus-host disease in critically ill patientsAlexander H Yang, Mai Ai Thanda Han, Niharika Samala, et al.
Hepatology (Baltimore, Md.)|January 27, 2010
Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trialJames E Everhart, Elizabeth C Wright, Zachary D Goodman, et al.
Transplantation and Cellular Therapy|July 25, 2022
Characterization of Hepatic Dysfunction in Subjects Diagnosed With Chronic GVHD by NIH Consensus CriteriaAlexander H Yang, Ma Ai Thanda Han, Niharika Samala, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis CJules L Dienstag, Marc G Ghany, Timothy R Morgan, et al.
Hepatology (Baltimore, Md.)|May 13, 2009
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trialTania Mara Welzel, Timothy R Morgan, Herbert L Bonkovsky, et al.
Pageof 8